GaBI - Generics and Biosimilars Initiative

Bellen Routebeschrijving Website Contact opnemen met de school

GaBI - Generics and Biosimilars Initiative GaBI's mission - Building trust in cost-effective treatments

GaBI Online is a one-stop portal for global news on the recent developments in the field of generics and biosimilars, a repository of worldwide guidelines and an archive of related scientific information. GaBI Journal (official Journal of the Generics and Biosimilars Initiative) is an independent and peer reviewed academic Journal - encompasses all aspects of generic and biosimilar medicines development and use, from fundamental research to clinical application and policies.

✨ Meet Our Speaker: Ronald P Jordan, RPh, FAPhA ✨The role of the pharmacist is changing faster than ever, but are regula...
14/10/2026

✨ Meet Our Speaker: Ronald P Jordan, RPh, FAPhA ✨
The role of the pharmacist is changing faster than ever, but are regulatory definitions keeping up? We’re excited to host Dean Emeritus of the Chapman University School of Pharmacy and Past President of the American Pharmacists Association, Ronald P Jordan, on October 15!
He will walk us through the evolving landscape of pharmacy practice and why maintaining clear boundaries between standard compounding and industrial manufacturing is essential for the future of the profession.
Seats are filling up quickly and capped. Grab yours now!
👉 Register now: https://us06web.zoom.us/webinar/register/WN_0NnBss8MTKK2de5Yy6_FZg

📢 Speaker Announcement! 📢What happens when the line between a traditional pharmacy and large-scale manufacturing starts ...
13/10/2026

📢 Speaker Announcement! 📢
What happens when the line between a traditional pharmacy and large-scale manufacturing starts to fade? Join us on Thursday, October 15, for an exclusive session featuring Dr Richard O Dolinar, practicing endocrinologist and Past Chairman of the Alliance for Safe Biologic Medicines.
Dr Dolinar will share his frontline insights on what these shifting regulatory boundaries mean for the daily safety and care of patients dealing with complex medical conditions.
⚠️ Seating is limited for this exclusive session. Click below to lock in your spot!
👉https://us06web.zoom.us/webinar/register/WN_0NnBss8MTKK2de5Yy6_FZg

🚨 Speaker Spotlight: Former FDA Associate Commissioner Peter J PittsWhen compounding pharmacies begin to look like indus...
13/10/2026

🚨 Speaker Spotlight: Former FDA Associate Commissioner Peter J Pitts
When compounding pharmacies begin to look like industrial factories, how should federal regulators respond? Find out on Thursday, October 15, during our highly anticipated webinar.
We’re sitting down with Peter J Pitts, President of the Center for Medicine in the Public Interest and former FDA Associate Commissioner, to dive deep into the legal, policy, and safety parameters that keep our drug supply chain secure.
This live session has limited access. Don’t miss your chance to learn directly from a former federal regulator!
👉 Register now: https://us06web.zoom.us/webinar/register/WN_0NnBss8MTKK2de5Yy6_FZg

📢 What are the hidden patient safety risks when mass-marketed compounded medications bypass traditional manufacturing re...
12/10/2026

📢 What are the hidden patient safety risks when mass-marketed compounded medications bypass traditional manufacturing regulations?
SafeBiologics and GaBI invite you to a high-priority joint briefing featuring expert speaker Philip J Schneider, MS, FASHP, International Advisory Board Chair for the Alliance for Safe Biologic Medicines.
As one of our 5 featured experts, Phil will outline the vital differences between traditional compounding and commercial manufacturing. If you are a doctor, pharmacist, or healthcare stakeholder, you cannot afford to miss this 1-hour session.
🗓️ Thursday, 15 October 2026
🕐 13:00 – 14:00 pm (ET)
👉 Click below to register and access the full presenter layout:
https://us06web.zoom.us/webinar/register/WN_0NnBss8MTKK2de5Yy6_FZg

📢 Don't miss this critical healthcare policy discussion! SafeBiologics and GaBI are bringing together a powerhouse panel...
12/10/2026

📢 Don't miss this critical healthcare policy discussion! SafeBiologics and GaBI are bringing together a powerhouse panel to discuss "COMPOUNDING THE PROBLEM: The Blurring of Pharmacy and Manufacturing."
We are pleased to feature Michael S Reilly, Esq, Executive Director of the Alliance for Safe Biologic Medicines, as one of our 5 expert faculty speakers leading this vital conversation on patient safety and drug quality.
If you are a healthcare professional, pharmacist, or policy stakeholder, this 1-hour briefing is built for you.
🗓️ Thursday, 15 October 2026
🕐 13:00 – 14:00 pm (ET)
👉 Click the link to register and view the full speaker faculty:
https://us06web.zoom.us/webinar/register/WN_0NnBss8MTKK2de5Yy6_FZg

🏥 How is the blurring line between pharmacy compounding and mass manufacturing impacting patient safety?On Thursday, Oct...
09/10/2026

🏥 How is the blurring line between pharmacy compounding and mass manufacturing impacting patient safety?
On Thursday, October 15th at 1:00 PM ET, SafeBiologics and GaBI are hosting a live joint webinar featuring 5 expert speakers to discuss the latest clinical and regulatory updates you need to know.
👉 Click below to learn more and register:
https://us06web.zoom.us/webinar/register/WN_0NnBss8MTKK2de5Yy6_FZg

Adres

Postbus 10001
Mol
BE-2400

Telefoon

+32-474989572

Website

,

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer GaBI - Generics and Biosimilars Initiative nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact Opnemen Met De School

Stuur een bericht naar GaBI - Generics and Biosimilars Initiative:

Snelkoppelingen

Delen